Gillian Greig
TransCanada (Canada)(CA)Merck Canada Inc. (Canada)(CA)
Publications by Year
Research Areas
Inflammatory mediators and NSAID effects, Receptor Mechanisms and Signaling, Asthma and respiratory diseases, Synthesis and biological activity, Chromosomal and Genetic Variations
Most-Cited Works
- → Characterization of the human cysteinyl leukotriene CysLT1 receptor(1999)969 cited
- → Gene for von Recklinghausen Neurofibromatosis Is in the Pericentromeric Region of Chromosome 17(1987)695 cited
- Uniparental disomy as a mechanism for human genetic disease.(1988)
- → Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2(2001)457 cited
- → Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitor(1997)326 cited
- → Discovery of a Potent and Selective Prostaglandin D2 Receptor Antagonist, [(3R)-4-(4-Chloro- benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic Acid (MK-0524)(2007)170 cited
- → 2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: Selective and orally active cyclooxygenase-2 inhibitors(1998)128 cited
- → Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells(1996)111 cited
- → PCR amplification of chromosome-specific alpha satellite DNA: Definition of centromeric STS markers and polymorphic analysis(1991)108 cited
- → The C3a receptor antagonist SB 290157 has agonist activity(2005)92 cited